R. Hare

Publication List Details

Period

1956 - 2006

Number

43

Co-Authors

Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study (2006)

Mant, J, McManus, R.J., Hare, R.

Objective To compare the characteristics of patients with cerebrovascular disease in primary care with those of the participants in the PROGRESS trial, on which national guidelines for blood pressure...

What do stroke patients and their carers want from community services? (2006)

Hare, R, Rogers, H, Lester, H, McManus, RJ, Mant, J

Background. Previous research has focused on the longer term needs of ‘new’ stroke patients at fixed time intervals after the event, but neglected those of stroke patients who may have had the...

What do stroke patients and their carers want from community services? (2005)

Hare, R., Rogers, H., Lester, H., McManus, R. J., Mant, J.

Background. Previous research has focused on the longer term needs of ‘new’ stroke patients at fixed time intervals after the event, but neglected those of stroke patients who may have had the...

Characterization and transcriptional regulation of the 2'-N-acetyltransferase gene from Providencia stuartii. (1993)

Rather, P N, Orosz, E, Shaw, K J, Hare, R, Miller, G

We have cloned the chromosomally encoded 2'-N-acetyltransferase gene [aac(2')-Ia] from Providencia stuartii. DNA sequence analysis of the cloned insert identified a single open reading frame, which...

b). "Precise Marine DGPS Positioning Using P code and High Performance C/A Code Technologies (1993)

G. Lachapelle, Congyu Liu, Gang Lu, M. E. Cannon, B. Townsend, R. Hare, ...

Geomatics Engineering where they are responsible for teaching and research related to positioning, navigation and hydrography. They have been involved with GPS development and applications since the...

Gram-negative bacilli resistant to third-generation cephalosporins: {beta}Mactamase characterization and susceptibility to Sch 34343 (1985)

Medeiros, A. A., Hare, R., Papa, E., Adam, C., Miller, G. H.

We studied 192 recent clinical isolates, comprising six species of Gram-negative bacilli resistant either to cefotaxime or latamoxef (Moxalactam), from several hospitals. All isolates were resistant...

Evaluation of the in-vitro antibacterial activity of Sch 34343 (1985)

Adam, C., Naples, L., Weiss, W., Sabatelli, F., Hare, R., Loebenberg, D., ...

The in-vitro activity (as measured by geometric mean MICs, mg/1) of Sch 34343 against aerobic and anaerobic bacteria was compared with that of 14 other selected β-lactam antibiotics including...

Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint

Drusano, G. L., Preston, S. L., Hardalo, C., Hare, R., Banfield, C., Andes, D., ...

One of the most challenging issues in the design of phase II/III clinical trials of antimicrobial agents is dose selection. The choice is often based on preclinical data from pharmacokinetic (PK)...

Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.

Rasmussen, B A, Bush, K, Keeney, D, Yang, Y, Hare, R, O'Gara, C, ...

In 1984, a year prior to the U.S. approval of imipenem for clinical use, a wound isolate and a bile isolate of Enterobacter cloacae were obtained from two patients in a California hospital. These...

Characterization and transcriptional regulation of the 2'-N-acetyltransferase gene from Providencia stuartii.

Rather, P N, Orosz, E, Shaw, K J, Hare, R, Miller, G

We have cloned the chromosomally encoded 2'-N-acetyltransferase gene [aac(2')-Ia] from Providencia stuartii. DNA sequence analysis of the cloned insert identified a single open reading frame, which...

Posaconazole as Salvage Therapy for Zygomycosis

Greenberg, R. N., Mullane, K., Raad, I., Abzug, M. J., Anstead, G., ...

Zygomycosis, an infection that is associated with significant morbidity and mortality, is becoming common in immunocompromised patients. Posaconazole is a new extended-spectrum azole antifungal that...

Identification of stroke in the community: a comparison of three methods.

Mant, J, McManus, R J, Hare, R, Mayer, P

BACKGROUND: Evidence concerning secondary prevention of cerebrovascular disease is not optimally used in clinical practice. A necessary first step is to identify those eligible for treatment. In...

In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts

Sabatelli, F., Patel, R., Mann, P. A., Mendrick, C. A., Norris, C. C., Hare, R., ...

The in vitro activity of the novel triazole antifungal agent posaconazole (Noxafil; SCH 56592) was assessed in 45 laboratories against approximately 19,000 clinically important strains of yeasts and...

Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC Breakpoint

Drusano, G. L., Preston, S. L., Hardalo, C., Hare, R., Banfield, C., Andes, D., ...

One of the most challenging issues in the design of phase II/III clinical trials of antimicrobial agents is dose selection. The choice is often based on preclinical data from pharmacokinetic (PK)...

Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.

Rasmussen, B A, Bush, K, Keeney, D, Yang, Y, Hare, R, O'Gara, C, ...

In 1984, a year prior to the U.S. approval of imipenem for clinical use, a wound isolate and a bile isolate of Enterobacter cloacae were obtained from two patients in a California hospital. These...

Characterization and transcriptional regulation of the 2'-N-acetyltransferase gene from Providencia stuartii.

Rather, P N, Orosz, E, Shaw, K J, Hare, R, Miller, G

We have cloned the chromosomally encoded 2'-N-acetyltransferase gene [aac(2')-Ia] from Providencia stuartii. DNA sequence analysis of the cloned insert identified a single open reading frame, which...

Identification of stroke in the community: a comparison of three methods.

Mant, J, McManus, R J, Hare, R, Mayer, P

BACKGROUND: Evidence concerning secondary prevention of cerebrovascular disease is not optimally used in clinical practice. A necessary first step is to identify those eligible for treatment. In...

Posaconazole as Salvage Therapy for Zygomycosis

Greenberg, R. N., Mullane, K., Raad, I., Abzug, M. J., Anstead, G., ...

Zygomycosis, an infection that is associated with significant morbidity and mortality, is becoming common in immunocompromised patients. Posaconazole is a new extended-spectrum azole antifungal that...

In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts

Sabatelli, F., Patel, R., Mann, P. A., Mendrick, C. A., Norris, C. C., Hare, R., ...

The in vitro activity of the novel triazole antifungal agent posaconazole (Noxafil; SCH 56592) was assessed in 45 laboratories against approximately 19,000 clinically important strains of yeasts and...

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

Hobbs, F D R, Davis, R C, Roalfe, A K, Hare, R, Davies, M K

Objective: To determine the performance of a new NT-proBNP assay in comparison with brain natriuretic peptide (BNP) in identifying left ventricular systolic dysfunction (LVSD) in randomly selected...